Recent

% | $
Quotes you view appear here for quick access.

Curis, Inc. Message Board

cash2go 143 posts  |  Last Activity: 4 hours ago Member since: Feb 8, 2006
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • March 25, 2015
    Emergent Bio developed the treatment, Anthrasil, as part of a $160 million contract it signed in 2005 with the Biomedical Advanced Research and Development Authority (BARDA), a part of the HHS.

    The drug, which is approved in combination with other antibacterials, is already being stored in the U.S. Strategic National Stockpile, the company said on Wednesday.
    ***********************************************************************************

    Siga management needs to focus on an FDA approval ASAP, the milestone payment will be good for both parties. Good to see the FDA is willing to do their part.

  • Reply to

    PIP BASHERS GETTING NERVOUS AS APRIL APPROACHES!

    by lelhill Mar 31, 2015 7:20 AM

    wheels of justice grind slowly

    With the best legal team a billionaire can buy you can really slow those wheels. Good thing the boyz at Siga have to watch that $30,000/day add up. Probably a top notch accounting/legal team now watching the clock.

  • Reply to

    Not sgen, but interesting cancer trial

    by dpemco Mar 31, 2015 12:12 AM

    Final part of series will be on tonight on PBS. Ken Burns does another incredible documentary job. Helps us not so smart understand the complexity of medicine and other subjects.

  • Reply to

    Not sgen, but interesting cancer trial

    by dpemco Mar 31, 2015 12:12 AM

    CAR T is the latest cancer treatment direction. Some trials showing actual cures. Another promising CAR T used the HIV virus/immune system to target a cancer and had great results. From what I see it this new therapy compares to the Dendreon's Provenge autologous therapy. It differs in one aspect that would be a target for investors. Provenge is a $100,000 tx, these new CAR T's look like a $500,000 tx, health system can't afford that.

    Anyone know if SGEN can take advantage of this immunotherapy and make it affordable?

  • Reply to

    $30,000 daily continues

    by cash2go Mar 26, 2015 10:54 AM
    cash2go cash2go Mar 26, 2015 11:06 AM Flag

    Look at the Pharmathene recent reorganization plan and think what may happen when Siga presents their reorganization plan due in July. The Boyz need to settle so they can continue to line their pockets without BK court weighing in on how much has been spent on this bad faith lawyered up creation.

    Siga now in OTC status, does Pharmathene get a look at bonus's being handed out to management team, lawyers and the accounting team?

  • Then you have Chapter 11 looking at this type of compensation:

    As Chief Executive Officer, Director at SIGA TECHNOLOGIES INC, Eric A. Rose M.D. made $1,646,000 in total compensation. Of this total $721,000 was received as a salary, $360,500 was received as a bonus, $0 was received in stock options, $564,000 was awarded as stock and $500 came from other types of compensation. This information is according to proxy statements filed for the 2013 fiscal year

  • Reply to

    Insider buy, open market

    by teebrane Mar 23, 2015 6:25 PM
    cash2go cash2go Mar 24, 2015 9:43 AM Flag

    Thanks for sharing that one. Always a favorite indicator.

  • to license ImmunoGen’s antibody-drug conjugate technology

    Nice bump in stock price on an upfront payment that was not very impressive. Wall Street is squeezing the shorts with this news.

    GLTA

  • Reply to

    SIGA-Q?

    by drod4ball Mar 23, 2015 2:03 PM
    cash2go cash2go Mar 23, 2015 3:23 PM Flag

    I think quagmire is pretty accurate when you are talking about the lawyered up mess Siga has created. It's an intentional quagmire according to the Delaware Courts, done with Bad Faith and ill will.

  • Earnings not what you would like to see with the recent real estate rebound? Summer should be the biggest chance of a positive earnings surprise. Now Cramer mentioned JOE as a possible so could get a short term bump for those trading this one, my guess.

    Not a trader so take the post with a big grain of salt.

  • Merger, buyout or litigation? Siga reorg plan due in July. Hope good things are coming soon to all small shareholders.

  • Reply to

    SIGA-Q?

    by drod4ball Mar 23, 2015 2:03 PM
    cash2go cash2go Mar 23, 2015 2:39 PM Flag

    OTC listing. Small investors will have few rights that Nasdaq listed stockholders have. Make sure you have a huge trust in management before "investing" in OTC stocks, otherwise they are just trading symbols.

  • Realignment Plan for Pharmathene

    On March 9, 2015, our Board of Directors approved a plan to preserve and maximize, for the benefit of our stockholders, the value of any proceeds from the SIGA litigation and our existing biodefense assets.
    *******************************************************************************************************************

    Wouldn't all the small investors in both companies like to see this kind of action from Siga and RP?

  • Reply to

    American Bar Association

    by cash2go Mar 23, 2015 12:59 AM
    cash2go cash2go Mar 23, 2015 1:10 AM Flag

    An Interview with The Honorable Donald F. Parsons, Jr.
    20 Dec 2011
    By:
    Denise Seastone Kraft

    Vice Chancellor Parsons: I graduated from Georgetown University Law Center in 1977. Before that, I received a B.S. in electrical engineering from Lehigh University. I intended on becoming a commercial litigator, but about three years into practicing, I had my first trade secret case and everything changed. I was drawn to intellectual property cases because they were so fact-intensive and complemented my engineering background. I just like complicated cases. I eventually litigated well over 100 intellectual property cases as lead and Delaware local counsel.

  • Investopedia says:

    What Delisting Means for the Company
    When a stock is officially delisted in the United States, there are two main places it can trade:

    Over the Counter Bulletin Board (OTCBB) - This is an electronic trading service offered by the Financial Industry Regulatory Authority (FINRA, formerly the NASD); it has very little regulation. Companies will trade here if they are current in their financial statements.
    Pink Sheets - Considered even riskier than the OTCBB, the pink sheets are a quotation service. They do not require that companies register with the Securities and Exchange Commission (SEC) or remain current in their periodic filings. The stocks on the pink sheets are very speculative.

  • Business Law Today
    C. Stephen Bigler, Jennifer Veet Barrett said/predicted:

    ...Although the Court of Chancery has yet to determine on remand in SIGA whether there is sufficient evidence to support an award of expectation damages to remedy SIGA’s breach of an agreement to negotiate in good faith, previous decisions of the Delaware courts where expectation damages have been awarded to remedy a breach of contract provide some guidance as to what type of evidence is sufficient to prove expectation damages with reasonable certainty. In that regard, Delaware courts have found that evidence of the expectations of the non-breaching party as to value of the business transaction, such as projections, prepared at the time the transaction was being negotiated and provided to a third party is a fair representation of the expectations of the non-breaching party sufficient to support an award of expectation damages.

    ***********************************************************************************************************************
    Law360, Los Angeles (January 15, 2015, 8:29 PM ET) -- The Delaware Chancery Court on Wednesday ordered SIGA Technologies Inc. to pay PharmAthene Inc. $195 million, including costs and pre- and post-judgment interest, for the expected profits PharmAthene would have earned

  • cash2go cash2go Mar 19, 2015 10:54 AM Flag

    CAR-T early estimates put per treatment patient at $500,000 yearly. How quickly would that bankrupt a nation?

  • cash2go cash2go Mar 19, 2015 10:11 AM Flag

    Siga lawyers and Siga accounting, it's what you expect from an OTC company. Bad faith and ill will.

    BARDA would be a good character witness, see the 2.8 billion contractual agreement with Siga they were forced out of by legal action.

  • Reply to

    so..

    by ebjm2004 Mar 18, 2015 8:19 PM
    cash2go cash2go Mar 19, 2015 2:25 AM Flag

    Pink sheet and OTCBB stocks lack the stringent regulation requirements that investors come to expect from NYSE and Nasdaq-traded stocks. Investors are willing to pay a premium for shares of trustworthy companies and are (understandably) leery of firms with shady reputations.

  • Reply to

    so..

    by ebjm2004 Mar 18, 2015 8:19 PM
    cash2go cash2go Mar 19, 2015 2:24 AM Flag

    Investopedia says:

    What Delisting Means for the Company
    When a stock is officially delisted in the United States, there are two main places it can trade:

    Over the Counter Bulletin Board (OTCBB) - This is an electronic trading service offered by the Financial Industry Regulatory Authority (FINRA, formerly the NASD); it has very little regulation. Companies will trade here if they are current in their financial statements.
    Pink Sheets - Considered even riskier than the OTCBB, the pink sheets are a quotation service. They do not require that companies register with the Securities and Exchange Commission (SEC) or remain current in their periodic filings. The stocks on the pink sheets are very speculative.

CRIS
2.35-0.05(-2.08%)Apr 1 4:00 PMEDT